BSX · News · 20260818N
Stock Repurchase Program
BOSTON SCIENTIFIC CORP · 2026-08-18 · Importance 64 · Surprise 42 · In source text
Boston Scientific authorized a $5 billion share buyback plan. The authorization was cited alongside the company’s recently reported strong quarterly earnings. The repurchase program indicates management’s stated confidence in the company’s valuation and supports capital allocation to shareholders.
Key facts
- Boston Scientific authorized a $5 billion share buyback plan. source
- Boston Scientific's stock declined by 46% from the start of 2026. source
- Boston Scientific reported stronger-than-expected Q2 2026 results, including increased margins and adjusted EPS that surpassed guidance. source
- Conway Capital Management Inc. purchased 28,750 shares of Boston Scientific valued at approximately $1.23 million. source
- Boston Scientific's stock is trading in the low $51 range. source
- The average analyst target price for Boston Scientific is $71.62. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | negative | committed | -9.4% | Boston Scientific authorized a $5 billion share buyback plan. |